Succinate Promotes M1 Polarization of Intestinal Macrophages in Mice With Necrotizing Enterocolitis Through the PI3K/AKT Pathway

Abstract

Necrotizing enterocolitis (NEC) is a devastating gastrointestinal disorder that frequently affects premature infants, and its pathogenesis is closely related to macrophage polarization. This study investigated the effects of succinate, a metabolite of the intestinal flora, on macrophage polarization in NEC. Succinate aggravated intestinal injury caused by NEC and inhibited the proliferation of damaged mouse monocyte‒macrophage leukemia cells (RAW264.7 cells). It was confirmed by multiple methods that succinate intervention promotes the polarization of intestinal macrophages toward the M1 phenotype in neonatal NEC. This polarization was characterized by a significant upregulation of inducible nitric oxide synthase (iNOS) protein levels and iNOS mRNA expression, along with a marked suppression of arginase 1 (ARG1) protein levels and Arg1 mRNA expression. Moreover, immunofluorescence analysis revealed that in the NEC intestine, the coexpression of the M1 macrophage marker F4/80⁺/CD86⁺ was significantly increased, whereas the coexpression of the M2 macrophage marker F4/80⁺/CD206⁺ was significantly decreased. Mechanistic studies revealed that succinate upregulated the expression levels of phosphorylated protein kinase B (p-AKT) and hypoxia-inducible factor 1 alpha (HIF1a) by activating the PI3K/AKT signaling pathway through its specific receptor succinate receptor 1 (SUCNR1). Further experiments revealed that the expression of polarization-related markers in M1-type macrophages was significantly suppressed after treatment with the SUCNR1-neutralizing antibody or the PI3K inhibitor LY294002. These findings suggest that succinate may activate the phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signaling pathway via SUCNR1 to promote the polarization of NEC macrophages toward the M1 phenotype, thereby accelerating NEC progression.

Keywords

macrophage polarization / necrotizing enterocolitis / PI3K/AKT / succinate

References

[1] T.-T. Du, X.-C. Liu, Y. He, et al., “Changes of Gut Microbiota and Tricarboxylic Acid Metabolites May Be Helpful in Early Diagnosis of Necrotizing Enterocolitis: A Pilot Study,” Frontiers in Microbiology14 (2023): 1119981, https://doi.org/10.3389/fmicb.2023.1119981.

[2] A. G. Roberts, N. Younge, and R. G. Greenberg, “Neonatal Necrotizing Enterocolitis: An Update on Pathophysiology, Treatment, and Prevention,” Pediatric Drugs26, no. 3 (2024): 259-275, https://doi.org/10.1007/s40272-024-00626-w.

[3] J. Chen, X. Chen, X. Huang, J. Liu, and Q. Yu, “Comparative Efficacy of Different Single Drugs to Prevent Necrotizing Enterocolitis in Preterm Infants: An Update Systematic Review and Network Meta-Analysis,” Frontiers in Nutrition11 (2024): 1452338, https://doi.org/10.3389/fnut.2024.1452338.

[4] I. D’Apremont, G. Marshall, C. Musalem, et al., “Trends in Perinatal Practices and Neonatal Outcomes of Very Low Birth Weight Infants During a 16-Year Period at NEOCOSUR Centers,” Journal of Pediatrics225 (2020): 44.e1-50.e1, https://doi.org/10.1016/j.jpeds.2020.05.040.

[5] I. H. Jones and N. J. Hall, “Contemporary Outcomes for Infants With Necrotizing Enterocolitis: A Systematic Review,” Journal of Pediatrics220 (2020): 86-92.e3, https://doi.org/10.1016/j.jpeds.2019.11.011.

[6] J. A. Berken and J. Chang, “Neurologic Consequences of Neonatal Necrotizing Enterocolitis,” Developmental Neuroscience44, no. 4–5 (2022): 295-308, https://doi.org/10.1159/000525378.

[7] L. Blum, D. Vincent, M. Boettcher, and J. Knopf, “Immunological Aspects of Necrotizing Enterocolitis Models: A Review,” Frontiers in Immunology15 (2024): 1434281, https://doi.org/10.3389/fimmu.2024.1434281.

[8] X. Cai, A. Golubkova, and C. J. Hunter, “Advances in Our Understanding of the Molecular Pathogenesis of Necrotizing Enterocolitis,” BMC Pediatrics22, no. 1 (2022): 225, https://doi.org/10.1186/s12887-022-03277-3.

[9] A. Kaplina, S. Kononova, E. Zaikova, T. Pervunina, N. Petrova, and S. Sitkin, “Necrotizing Enterocolitis: The Role of Hypoxia, Gut Microbiome, and Microbial Metabolites,” International Journal of Molecular Sciences24, no. 3 (2023): 2471, https://doi.org/10.3390/ijms24032471.

[10] J. W. Duess, M. E. Sampah, C. M. Lopez, et al., “Necrotizing Enterocolitis, Gut Microbes, and Sepsis,” Gut Microbes15, no. 1 (2023): 2221470, https://doi.org/10.1080/19490976.2023.2221470.

[11] M. E. S. Sampah and D. J. Hackam, “Dysregulated Mucosal Immunity and Associated Pathogeneses in Preterm Neonates,” Frontiers in Immunology11 (2020): 899, https://doi.org/10.3389/fimmu.2020.00899.

[12] S. Yu, Z. Lv, Z. Gao, et al., “Hydrogen Promotes the M1 Macrophage Conversion During the Polarization of Macrophages in Necrotizing Enterocolitis,” Frontiers in Pediatrics9 (2021): 710382, https://doi.org/10.3389/fped.2021.710382.

[13] Y. Zhang, Y. Tian, X. Zhong, et al., “RNF₃1-Mediated IKKα Ubiquitination Aggravates Inflammation and Intestinal Injury Through Regulating NF-κB Activation in Human and Mouse Neonates,” Life Sciences352 (2024): 122893, https://doi.org/10.1016/j.lfs.2024.122893.

[14] J. L. K. Yip, G. K. Balasuriya, S. J. Spencer, and E. L. Hill-Yardin, “The Role of Intestinal Macrophages in Gastrointestinal Homeostasis: Heterogeneity and Implications in Disease,” Cellular and Molecular Gastroenterology and Hepatology12, no. 5 (2021): 1701-1718, https://doi.org/10.1016/j.jcmgh.2021.08.021.

[15] Y. Luo, D. Mo, H. Guo, et al., “NF-κB Inactivation Attenuates the M1 Macrophage Polarization in Experimental Necrotizing Enterocolitis by Glutaredoxin-1 Deficiency,” Cell Biology International46, no. 11 (2022): 1886-1899, https://doi.org/10.1002/cbin.11861.

[16] N. Monzon, E. M. Kasahara, A. Gunasekaran, K. Y. Burge, and H. Chaaban, “Impact of Neonatal Nutrition on Necrotizing Enterocolitis,” Seminars in Pediatric Surgery32, no. 3 (2023): 151305, https://doi.org/10.1016/j.sempedsurg.2023.151305.

[17] A. Cuna, M. J. Morowitz, I. Ahmed, S. Umar, and V. Sampath, “Dynamics of the Preterm Gut Microbiome in Health and Disease,” American Journal of Physiology—Gastrointestinal and Liver Physiology320, no. 4 (2021): G411-G419, https://doi.org/10.1152/ajpgi.00399.2020.

[18] X.-L. Yan, X.-C. Liu, Y.-N. Zhang, et al., “Succinate Aggravates Intestinal Injury in Mice With Necrotizing Enterocolitis,” Frontiers in Cellular and Infection Microbiology12 (2022): 1064462, https://doi.org/10.3389/fcimb.2022.1064462.

[19] G. Gradisteanu Pircalabioru, I. Ilie, L. Oprea, et al., “Microbiome, Mycobiome and Related Metabolites Alterations in Patients With Metabolic Syndrome-a Pilot Study,” Metabolites12, no. 3 (2022): 218, https://doi.org/10.3390/metabo12030218.

[20] M. Qiu, C. Ye, X. Zhao, et al., “Succinate Exacerbates Mastitis in Mice via Extracellular Vesicles Derived From the Gut Microbiota: A Potential New Mechanism for Mastitis,” Journal of Nanobiotechnology22, no. 1 (2024): 712, https://doi.org/10.1186/s12951-024-02997-1.

[21] V. Ceperuelo-Mallafré, G. Llauradó, N. Keiran, et al., “Preoperative Circulating Succinate Levels as a Biomarker for Diabetes Remission After Bariatric Surgery,” Diabetes Care42, no. 10 (2019): 1956-1965, https://doi.org/10.2337/dc19-0114.

[22] S. Wang, B. Liu, J. Huang, et al., “Succinate and Mitochondrial DNA Trigger Atopic March From Atopic Dermatitis to Intestinal Inflammation,” Journal of Allergy and Clinical Immunology151, no. 4 (2023): 1050-1066.e7, https://doi.org/10.1016/j.jaci.2022.11.026.

[23] X. Li, G. Huang, Y. Zhang, et al., “Succinate Signaling Attenuates High-Fat Diet-Induced Metabolic Disturbance and Intestinal Barrier Dysfunction,” Pharmacological Research194 (2023): 106865, https://doi.org/10.1016/j.phrs.2023.106865.

[24] W. Jiang, Y.-P. Han, M. Hu, X.-Q. Bao, Y. Yan, and G. Chen, “A Study on Regulatory Mechanism of miR-223 in Ulcerative Colitis Through PI3K/Akt-mTOR Signaling Pathway,” European Review for Medical and Pharmacological Sciences23, no. 11 (2019): 4865-4872, https://doi.org/10.26355/eurrev_201906_18074.

[25] T. Pan, S. Sun, Y. Chen, et al., “Immune Effects of PI3K/Akt/HIF-1α-Regulated Glycolysis in Polymorphonuclear Neutrophils During Sepsis,” Critical Care26, no. 1 (2022): 29, https://doi.org/10.1186/s13054-022-03893-6.

[26] Y.-H. Wang, Z.-Z. Yan, S.-D. Luo, et al., “Gut Microbiota-Derived Succinate Aggravates Acute Lung Injury After Intestinal Ischaemia/Reperfusion in Mice,” European Respiratory Journal61, no. 2 (2023): 2200840, https://doi.org/10.1183/13993003.00840-2022.

[27] D.-D. Zhang, Z.-X. Huang, X.-C. Liu, et al., “Butyrate Protects the Intestinal Barrier by Upregulating Fut2 Expression via MEK4-JNK Signaling Pathway Activation,” Pediatric Research97, no. 1 (2025): 128-137, https://doi.org/10.1038/s41390-024-03419-6.

[28] Q.-G. Lu, L. Zeng, X.-H. Li, et al., “Protective Effects of Panax notoginseng Saponin on Dextran Sulfate Sodium-Induced Colitis in Rats Through Phosphoinositide-3-Kinase Protein Kinase B Signaling Pathway Inhibition,” World Journal of Gastroenterology26, no. 11 (2020): 1156-1171, https://doi.org/10.3748/wjg.v26.i11.1156.

[29] M. D. Halpern, H. Holubec, T. A. Saunders, et al., “Bile Acids Induce Ileal Damage During Experimental Necrotizing Enterocolitis,” Gastroenterology130, no. 2 (2006): 359-372, https://doi.org/10.1053/j.gastro.2005.10.023.

[30] X. Yu, A. Radulescu, N. Zorko, and G. E. Besner, “Heparin-Binding EGF-Like Growth Factor Increases Intestinal Microvascular Blood Flow in Necrotizing Enterocolitis,” Gastroenterology137, no. 1 (2009): 221-230, https://doi.org/10.1053/j.gastro.2009.03.060.

[31] Z. Lv, X. Xu, Z. Sun, et al., “TRPV1 Alleviates Osteoarthritis by Inhibiting M1 Macrophage Polarization via Ca(2+)/CaMKII/Nrf2 Signaling Pathway,” Cell Death & Disease12, no. 6 (2021): 504, https://doi.org/10.1038/s41419-021-03792-8.

[32] S. Fernández-Veledo and J. Vendrell, “Gut Microbiota-Derived Succinate: Friend or Foe in Human Metabolic Diseases,” Reviews in Endocrine & Metabolic Disorders, 20, no. 4 (2019): 439-447, https://doi.org/10.1007/s11154-019-09513-z.

[33] Y.-H. Wei, X. Ma, J.-C. Zhao, X.-Q. Wang, and C.-Q. Gao, “Succinate Metabolism and Its Regulation of Host-Microbe Interactions,” Gut Microbes15, no. 1 (2023): 2190300, https://doi.org/10.1080/19490976.2023.2190300.

[34] D. C. Macias-Ceja, D. Ortiz-Masiá, P. Salvador, et al., “Succinate Receptor Mediates Intestinal Inflammation and Fibrosis,” Mucosal Immunology12, no. 1 (2019): 178-187, https://doi.org/10.1038/s41385-018-0087-3.

[35] S. Kadomoto, K. Izumi, and A. Mizokami, “Macrophage Polarity and Disease Control,” International Journal of Molecular Sciences23, no. 1 (2022): 144, https://doi.org/10.3390/ijms23010144.

[36] Y. Chen, M. Hu, L. Wang, and W. Chen, “Macrophage M1/M2 Polarization,” European Journal of Pharmacology877 (2020): 173090, https://doi.org/10.1016/j.ejphar.2020.173090.

[37] M. Locati, G. Curtale, and A. Mantovani, “Diversity, Mechanisms, and Significance of Macrophage Plasticity,” Annual Review of Pathology15, no. 1 (2020): 123-147, https://doi.org/10.1146/annurev-pathmechdis-012418-012718.

[38] M. L. Kovler, A. J. Gonzalez Salazar, W. B. Fulton, et al., “Toll-Like Receptor 4-Mediated Enteric Glia Loss Is Critical for the Development of Necrotizing Enterocolitis,” Science Translational Medicine13, no. 612 (2021): eabg3459, https://doi.org/10.1126/scitranslmed.abg3459.

[39] D. Mo, Y. Qiu, B. Tian, et al., “Progranulin Mitigates Intestinal Injury in a Murine Model of Necrotizing Enterocolitis by Suppressing M1 Macrophage Polarization,” Cell Biology International48, no. 10 (2024): 1520-1532, https://doi.org/10.1002/cbin.12209.

[40] W. He, F. J. P. Miao, D. C. H. Lin, et al., “Citric Acid Cycle Intermediates as Ligands for Orphan G-Protein-Coupled Receptors,” Nature429, no. 6988 (2004): 188-193, https://doi.org/10.1038/nature02488.

[41] A. Liu, Y. Liu, W. Zhang, and R. D. Ye, “Structural Insights Into Ligand Recognition and Activation of the Succinate Receptor SUCNR1,” Cell Reports43, no. 7 (2024): 114381, https://doi.org/10.1016/j.celrep.2024.114381.

[42] J.-Y. Wu, T.-W. Huang, Y.-T. Hsieh, et al., “Cancer-Derived Succinate Promotes Macrophage Polarization and Cancer Metastasis via Succinate Receptor,” Molecular Cell77, no. 2 (2020): 213-227.e5, https://doi.org/10.1016/j.molcel.2019.10.023.

[43] J. Connors, N. Dawe, and J. Van Limbergen, “The Role of Succinate in the Regulation of Intestinal Inflammation,” Nutrients11, no. 1 (2019): 25, https://doi.org/10.3390/nu11010025.

[44] M. Pu, J. Zhang, F. Hong, et al., “The Pathogenic Role of Succinate-SUCNR1: A Critical Function That Induces Renal Fibrosis via M2 Macrophage,” Cell Communication and Signaling22, no. 1 (2024): 78, https://doi.org/10.1186/s12964-024-01481-5.

[45] L. Liu, W. Tang, S. Wu, J. Ma, and K. Wei, “Pulmonary Succinate Receptor 1 Elevation in High-Fat Diet Mice Exacerbates Lipopolysaccharides-Induced Acute Lung Injury via Sensing Succinate,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease1870, no. 5 (2024): 167119, https://doi.org/10.1016/j.bbadis.2024.167119.

[46] M. Acosta-Martinez and M. Z. Cabail, “The PI3K/Akt Pathway in Meta-Inflammation,” International Journal of Molecular Sciences23, no. 23 (2022): 15330, https://doi.org/10.3390/ijms232315330.

[47] J. Wang, K. Hu, X. Cai, et al., “Targeting PI3K/AKT Signaling for Treatment of Idiopathic Pulmonary Fibrosis,” Acta Pharmaceutica Sinica B12, no. 1 (2022): 18-32, https://doi.org/10.1016/j.apsb.2021.07.023.

[48] S. Wang, R. Liu, Q. Yu, L. Dong, Y. Bi, and G. Liu, “Metabolic Reprogramming of Macrophages During Infections and Cancer,” Cancer Letters452 (2019): 14-22, https://doi.org/10.1016/j.canlet.2019.03.015.

RIGHTS & PERMISSIONS

2025 The Author(s). Pediatric Discovery published by John Wiley & Sons Australia, Ltd on behalf of Children’s Hospital of Chongqing Medical University.